Press Releases

The Europe TIC Market for Pharmaceuticals and Biotech Industry reached USD 8.6 billion in 2030, currently, in year 2023 the market is USD 3.4 billion with a projected CAGR of 3.4% from 2025 to 2030. 

The pharmaceutical and biotech sectors' European Testing, Inspection, and Certification (TIC) market is expanding significantly due to stricter laws, rising healthcare product safety and quality demands, and supply chain globalization. The need for specialized certification services is being driven by the growing complexity and innovation in medical devices, especially implantable devices and in-vitro diagnostics. The medical devices segment is a significant area within the broader healthcare TIC market, with strong growth driven by strict regulations and the need to ensure safety. However, despite its goal of unity, the EU offers a diverse environment with distinct local review, reimbursement, and regulatory procedures in each member state, making it more difficult for medications and diagnostic combinations to consistently enter the market.

Browse market data Tables and Figures spread through 90 Pages and in-depth TOC on Europe TIC Market for Pharmaceuticals and Biotech Industry By Sourcing Type (In-House and Outsourced), By Service Type (Testing, Inspection and Certification), By Industry Vertical (In-Vitro Diagnostics, Dental Equipment, Ophthalmic Devices, Diagnostic Equipment, Hospital Supplies, Cardiovascular Devices, Surgical Equipment, Patient Monitoring Devices, Orthopaedic Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anaesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices, Implantable Devices, Batteries and Medical Components, Home Healthcare Devices and Others) and By Geography (Europe) - Forecast from 2025 to 2030.

Europe TIC Market for Pharmaceuticals and Biotech Industry Segmentation and Key Players

By sourcing, in-house dominated the Europe TIC market for pharmaceuticals and biotech industry. 

The highest share is in-house since it gives firms control over their technological, laboratory, skilled, and testing and measurement equipment processes through in-house testing, inspection, and certification.

"Germany dominated the Europe TIC market for pharmaceuticals and biotech industry." 

Germany dominates the Europe TIC market for Pharmaceuticals and Biotech Industry as it is a home to some of the world's leading pharmaceutical companies and regulatory bodies.

Some of the major players in this market are Intertek Group plc, Bureau Veritas, UL LLC, SGS SA, Eurofins Scientific, The British Standards Institution, ALS Limited, DEKRA SE, Applus+, TUV SUD

Europe TIC Market for Pharmaceuticals and Biotech Industry coverage (By Value) 

• Sourcing Insight and Forecast 2025 - 2030
  • In-House
  • Outsourced
• Service Type Insight and Forecast 2025 - 2030
  • Testing
  • Inspection
  • Certification
• Industry Vertical Insight and Forecast 2025 - 2030
  • Extractable and Leachable Studies
  • Environmental Monitoring
  • Biopharmaceutical and Biologics Analysis
  • Sterile Compounding
  • Pharmaceutical Method Development and Research
  • pharmaceutical X-ray Diffraction
  • Excipient Raw Materials and Container Testing
  • Material Sciences Testing
  • Disinfection Qualification
  • Trace Metal Services
  • Others

Geographical Segmentation

Europe TIC Market for Pharmaceuticals and Biotech Industry by Region

• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe